New 'all-tablet' treatment shows promise for common form of leukemia
An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...
The American Journal of Managed Care7h
Mirikizumab Demonstrates Superior Maintenance Efficacy in UC Treatment
Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Neurology Advisor1d
Leqembi Monthly IV Maintenance Dosing Approved for Early Alzheimer Disease
The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.
The American Journal of Managed Care13d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Healthline17d
Can Essential Oils Help with Crohn’s Disease?
It’s best to contact a doctor if you wish to consider including essential oils in your treatment plan for Crohn’s disease. Your doctor can advise on the safety of the oils and whether they may ...
healthday20d
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
THURSDAY, Jan. 16, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults, ...
U.S. News & World Report21d
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
Omvoh is the first biological treatment for Crohn disease to have disclosed two-year phase 3 efficacy data at the time of approval in more than 15 years. The approval is based on results of the ...
Daily21d
USFDA approves Eli Lilly Omvoh for Crohn's disease
Indianapolis: Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's ...
Wall Street Journal21d
Eli Lilly Receives FDA Approval for Crohn’s Disease Treatment
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...
WebMD21d
FDA Approves Omvoh for Crohn’s Disease
16, 2025 – The FDA has approved the drug Omvoh for treating adults with moderately to severely active Crohn's ... bowel disease, after its October 2023 approval as a first-in-class treatment ...
Pharm Exec21d
FDA Approves Eli Lilly’s Omvoh for Crohn Disease
After dosing, patients received a maintenance dose of 300 mg by subcutaneous ... "With Omvoh approved in both Crohn's disease and ulcerative colitis, more patients now have a treatment option that may ...
Monthly Prescribing Reference21d
Omvoh Approved for Moderately to Severely Active Crohn Disease
Mirikizumab-treated patients achieved statistically significant clinical remission and endoscopic response compared with placebo at week 52. The Food and Drug Administration (FDA) has approved ...